Compass Therapeutics, Inc. (CMPX) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est ORBIMED ADVISORS LLC avec 15,219,994 actions. Parmi les autres détenteurs notables OrbiMed Genesis GP LLC et Schuetz Thomas J..
Au cours des 12 derniers mois, les initiés ont effectué 18 transactions sur CMPX l'action — 13 achats (d'une valeur de $25.24M) et 0 ventes (d'une valeur de RSU Award). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.
CMPX Participations des Initiés
Principal Actionnaire
ORBIMED ADVISORS LLC
15,219,994 actions
Achats (12 mois)
13
$25.24M valeur
Ventes (12 mois)
0
$0.00 valeur
Activité de transactions (12 mois)
Principaux actionnaires initiés
| # |
Nom |
Rôle |
Actions détenues |
Dernière déclaration |
Taille relative |
| 1 |
Orbimed Advisors Llc |
Director |
15,219,994 |
2022-11-10 |
|
| 2 |
Orbimed Genesis Gp Llc |
Director |
14,690,178 |
2022-05-13 |
|
| 3 |
Schuetz Thomas J. |
Chief Executive Officer |
6,603,336 |
2026-02-10 |
|
| 4 |
Tompkins Mark N. |
10 Percent Owner |
4,750,000 |
2018-07-30 |
|
| 5 |
Bisker-leib Vered |
Chief Executive Officer |
3,124,426 |
2024-02-09 |
|
| 6 |
Sunderland Julie |
Director |
2,212,907 |
2020-06-23 |
|
| 7 |
Sirard Cynthia |
Chief Medical Officer |
1,000,000 |
2026-01-05 |
|
| 8 |
Prasad Arjun |
Chief Commercial Officer |
1,000,000 |
2026-01-05 |
|
| 9 |
Shin Barry |
CFO |
525,000 |
2026-01-05 |
|
| 10 |
Anderson Errik |
10 Percent Owner |
383,642 |
2020-06-29 |
|
| 11 |
Lerner Neil |
Chief Accounting Officer |
382,500 |
2026-01-05 |
|
| 12 |
Jacobs Ian Seth |
President, Sec, CEO, & CFO |
250,000 |
2018-07-30 |
|
| 13 |
Anderman Jonathan |
General Counsel |
171,000 |
2026-01-05 |
|
| 14 |
Gordon Carl L |
Director |
90,000 |
2026-01-05 |
|
| 15 |
Chiniara Ellen |
Director |
90,000 |
2026-01-05 |
|
| 16 |
Boylan James P |
Director |
90,000 |
2026-01-05 |
|
| 17 |
Gray Mary Ann |
Director |
90,000 |
2026-01-05 |
|
| 18 |
Lindahl Richard S |
Director |
90,000 |
2026-01-05 |
|
| 19 |
Ferneau Philip |
Director |
90,000 |
2026-01-05 |
|
| 20 |
Kalled Susan |
Chief Scientific Officer |
60,000 |
2022-02-23 |
|
Transactions récentes (12 derniers mois)
| Date |
Nom |
Rôle |
Type |
Actions |
Prix |
Valeur |
| 2026-02-08 |
Schuetz Thomas J. |
Chief Executive Officer |
Retenue Fiscale RSU |
36,687 |
$6.52 |
$239.2K |
| 2026-01-09 |
Schuetz Thomas J. |
Chief Executive Officer |
Retenue Fiscale RSU |
46,777 |
$5.35 |
$250.26K |
| 2026-01-02 |
Prasad Arjun |
Chief Commercial Officer |
Attribution de RSU |
1,000,000 |
$5.17 |
$5.17M |
| 2026-01-02 |
Prasad Arjun |
Officer |
Inconnu |
- |
- |
- |
| 2026-01-02 |
Anderman Jonathan |
General Counsel |
Attribution de RSU |
150,000 |
$5.17 |
$775.5K |
| 2026-01-02 |
Boylan James P |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Ferneau Philip |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Sirard Cynthia |
Chief Medical Officer |
Attribution de RSU |
1,000,000 |
$5.17 |
$5.17M |
| 2026-01-02 |
Sirard Cynthia |
Officer |
Inconnu |
- |
- |
- |
| 2026-01-02 |
Shin Barry |
CFO |
Attribution de RSU |
125,000 |
$5.17 |
$646.25K |
| 2026-01-02 |
Schuetz Thomas J. |
CEO |
Attribution de RSU |
2,000,000 |
$5.17 |
$10.34M |
| 2026-01-02 |
Lerner Neil |
Chief Accounting Officer |
Attribution de RSU |
62,500 |
$5.17 |
$323.13K |
| 2026-01-02 |
Chiniara Ellen |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Gordon Carl L |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Gray Mary Ann |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Lindahl Richard S |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
| 2025-11-16 |
Schuetz Thomas J. |
Chief Executive Officer |
Retenue Fiscale RSU |
44,025 |
$4.83 |
$212.64K |
| 2025-05-27 |
Schuetz Thomas J. |
Chief Executive Officer |
Achat Informatif |
10,000 |
$2.11 |
$21.1K |
Les autres consultent aussi
